Advanced Diagnostics and Treatments for Adult Congenital Heart Disease

Our board-certified physicians at University Hospitals Harrington Heart & Vascular Institute and University Hospitals Rainbow Babies & Children’s Hospital’s adult congenital heart disease program are highly trained in all areas of heart care, using leading-edge diagnostic technology for evaluation, diagnosis and continued monitoring. Our team of specialists offer the following state-of-the-art, advanced diagnostic services:

  • Cardiac catheterizations – diagnostic and interventional
  • Cardiac computed tomography (CT)
  • Cardiac magnetic resonance imaging and angiography (MRI/MRA)
  • Echocardiograms (transthoracic, transesophageal, intracardiac)
  • Electrophysiology studies
  • Exercise stress tests
  • Optical coherence tomography
  • Intravascular ultrasound

Adult Congenital Heart Disease Interventional Program

After an evaluation and consultation, our team may recommend a comprehensive interventional approach that combines the expertise of both adult congenital heart disease specialists and adult cardiologists.

Available transcatheter therapies include:

  • Angioplasty and stenting of coarctation of the aorta
  • Transcatheter aortic valve replacement
  • Device closure of septal defects
  • Mitral valve repair
  • Occlusion of coronary fistula
  • Other complex congenital interventions
  • Patent ductus arteriosus closure
  • pulmonic valve replacement
  • Valve-in-valve replacement

Heart Transplant Clinic

Patients in more advanced stages of heart failure, may be referred to our heart transplant program. This team will evaluate each patient, based on their individualized needs, for mechanical circulatory support, which could possibly include heart transplant or heart-lung transplant.

Novel Treatments for Adult Congenital Heart Disease

With the wealth of leading-edge research available on treating adult congenital heart disease, our physicians at University Hospitals may recommend medically advanced novel therapies, including:

  • A bioresorbable (biodegradable) stent that is inserted into a narrowed blood vessel to increase flow and prevent future blockage
  • Implantable hemodynamic monitoring systems to follow pressures in the heart while the patient is at home
  • Mechanical assist devices such as the Total Artificial Heart that will play an increasingly important role in the surgical management of pediatric biventricular heart failure
  • New transcatheter valves and valve repair strategies to avoid needing to go to the operating room for open heart surgery